SMAD3 and urinary bladder carcinoma: In conclusion, this is the first study to demonstrate that LINC02470 plays a significant regulatory role in EMT promotion through the miR-143-3p–SMAD3 signaling pathway, thereby aggravating bladder cancer progression.